Drug Eluting Stent (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

  • TBI427739
  • August 19, 2020
  • Global
  • 132 pages
  • ROIF Expert
                                          

We have updated Drug Eluting Stent (DES) Market with respect to COVID-19 Business Impact. Inquire before buying This report focuses on the Drug Eluting Stent (DES) market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Drug Eluting Stent (DES) market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.

Global Drug Eluting Stent (DES) Market: Segment Analysis

The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.

Global Drug Eluting Stent (DES) Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.

Global Drug Eluting Stent (DES) Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.

List of Companies Profiled

Abbott, Medtronic, and Boston Scientific Corporation are some of the Leading Market Players The Drug Eluting Stent market is a consolidated market comprising of few key players. The competitive landscape consists of large, mid-size, and small companies that have developed different types of stents to target various indications. The market is largely dominated by a few key players, including Abbott, Medtronic, and Boston Scientific Corporation accounting for more than 50.0% of share. Innovation in DES, increase in number of clinical trials and investment in research & development, and step towards geographic expansion are some of the major strategies adopted by key market players operating in this market.

LIST OF KEY COMPANIES PROFILED:

KEY INDUSTRY DEVELOPMENTS:

February 2019 -Medtronic received FDA approval for Resolute DES platforms such as the Resolute Onyx and Resolute Integrity DES, for expanded indications such as de novo chronic total occlusion (CTO). February 2019 -BIOTRONIK received FDA approval for iOrsiro ultrathin DES designed for use in percutaneous coronary intervention procedures.

REPORT COVERAGE

The Drug Eluting Stent market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the market, current Drug Eluting Stent market trends and highlights the key industry developments. In addition, the report encompasses several factors that have contributed to the growth of the market over the recent years.

Report Scope & Segmentation

Segmentation

By Type

  • Coronary Stenting
  • Peripheral Stenting

By Scaffold

  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Others

By Drug

  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Others

By End User

  • Hospitals
  • Specialty Clinics

By Geography

  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)"
Table of Content
Chapter 1. Methodology and Scope 
1.1. Research Methodology 
1.2. Research Scope & Assumptions 
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Drug Eluting Stent (DES) Market
3.1. Market Segmentation 
3.2. Market Size and Growth Prospects, 2019 - 2029 
3.3. Value Chain Analysis 
3.4. Market Dynamics 
3.4.1. Market driver analysis 
3.4.2. Market restraint analysis
Chapter 4. Market Size by Application
4.1 Drug Eluting Stent (DES) Market Consumption by Application (2015-2020) 
4.2 Drug Eluting Stent (DES) Market Consumption by Application (2020-2029) 

|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form